F.-W. Niu, Y.-J. Zhang, K. Li, and M.-S. Zhang, “Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways”, Bangladesh J Pharmacol, vol. 9, no. 3, pp. 406–412, Sep. 2014.